CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination data for both mRNA-1010, i ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present late-breaking oral presentations on revaccination ...
Scientists at St. Jude Children's Research Hospital, the American Society for Hematology (ASH) and the Munich Leukemia ...
SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...
For UnitedHealthcare Medicare Advantage plans, only 2.5% of claims require prior authorization, excluding certain requests, ...
This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...
The FDA has expanded indications for two targeted combination treatments, Alyftrek and Trikafta, that will now benefit more ...
Tool gives cataract and refractive surgeons instant insight into their own clinical performance data — at no cost ...
Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage therapeutics company advancing novel neuropsychiatric ...
Shares of small biotech company Wave Life Sciences (WVE) have recently fallen sharply following the release of Phase 1 ...
JMIR Publications today announced the release of a timely new article in its News and Perspectives section, examining the ...
In an era where blood-sugar supplements flood the market with exaggerated promises, Gluco Armor stands out for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results